Hebei Changshan Biochemical Hits Day Low at CNY 23.73 Amid Price Pressure

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 3.99% as it reached an intraday low of CNY 23.73. This performance marks a stark contrast to the China Shanghai Composite, which saw a slight increase of 0.04% on the same day. Over the past week, Hebei Changshan has faced a 10.01% decrease, and its performance over the last month shows a decline of 14.08%. The company has struggled considerably over the past year, with a staggering 48.69% drop, while the broader market has gained 3.56%. Year-to-date, the stock has plummeted by 60.5%, significantly underperforming the market's decline of just 1.6%. Financial metrics indicate ongoing challenges for the company, including a negative net profit of CNY -322.94 million for the first nine months and a concerning average return on capital employed (ROCE) of only 3.59%. The stock's high price-to-book ratio of 20.70 and a debt-to-equity ratio of 2.08 further highlight its financial position. Overall, Hebei Changshan continues to face a difficult market environment, reflected in its recent stock performance.